Raymond James Financial Inc. acquired a new position in shares of WisdomTree, Inc. (NYSE:WT - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 405,946 shares of the company's stock, valued at approximately $4,262,000. Raymond James Financial Inc. owned 0.28% of WisdomTree as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also made changes to their positions in the business. Charles Schwab Investment Management Inc. lifted its position in shares of WisdomTree by 10.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,310,899 shares of the company's stock worth $13,764,000 after buying an additional 119,762 shares during the period. ExodusPoint Capital Management LP grew its holdings in shares of WisdomTree by 127.2% in the 4th quarter. ExodusPoint Capital Management LP now owns 1,162,993 shares of the company's stock worth $12,211,000 after purchasing an additional 651,121 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in WisdomTree by 157.4% during the 4th quarter. JPMorgan Chase & Co. now owns 880,489 shares of the company's stock valued at $9,245,000 after purchasing an additional 538,385 shares during the last quarter. Principal Financial Group Inc. boosted its position in WisdomTree by 2.8% in the fourth quarter. Principal Financial Group Inc. now owns 728,345 shares of the company's stock valued at $7,648,000 after buying an additional 19,503 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of WisdomTree by 188.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 722,586 shares of the company's stock worth $7,587,000 after buying an additional 472,505 shares in the last quarter. 78.64% of the stock is currently owned by institutional investors and hedge funds.
WisdomTree Price Performance
Shares of WT stock opened at $8.69 on Friday. The firm's 50 day moving average price is $8.63 and its two-hundred day moving average price is $9.86. The stock has a market cap of $1.28 billion, a PE ratio of 28.03 and a beta of 1.26. WisdomTree, Inc. has a 52-week low of $7.47 and a 52-week high of $12.45. The company has a debt-to-equity ratio of 1.28, a quick ratio of 2.13 and a current ratio of 2.92.
WisdomTree (NYSE:WT - Get Free Report) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($0.02). WisdomTree had a return on equity of 24.67% and a net margin of 15.59%. As a group, analysts forecast that WisdomTree, Inc. will post 0.72 EPS for the current year.
WisdomTree Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Wednesday, February 12th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend was Wednesday, February 12th. WisdomTree's payout ratio is presently 38.71%.
Insiders Place Their Bets
In related news, insider Alexis Marinof sold 90,980 shares of the business's stock in a transaction that occurred on Tuesday, February 4th. The stock was sold at an average price of $9.87, for a total value of $897,972.60. Following the completion of the transaction, the insider now directly owns 221,146 shares in the company, valued at approximately $2,182,711.02. The trade was a 29.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 7.80% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts recently commented on WT shares. Keefe, Bruyette & Woods decreased their price target on WisdomTree from $12.00 to $10.50 and set a "market perform" rating on the stock in a research report on Tuesday, January 14th. The Goldman Sachs Group reduced their price target on shares of WisdomTree from $9.75 to $8.50 and set a "sell" rating on the stock in a research report on Monday, April 14th. Finally, Northcoast Research lowered shares of WisdomTree from a "buy" rating to a "neutral" rating in a research report on Thursday, January 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $12.42.
Check Out Our Latest Research Report on WisdomTree
WisdomTree Profile
(
Free Report)
WisdomTree, Inc, through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans.
Recommended Stories
Want to see what other hedge funds are holding WT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for WisdomTree, Inc. (NYSE:WT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider WisdomTree, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WisdomTree wasn't on the list.
While WisdomTree currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.